TAIM
MRK icon

Te Ahumairangi Investment Management’s Merck MRK Stock Holding History

Te Ahumairangi Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.65M Sell
63,569
-18,657
-23% -$2.15M 1.28% 25
2025
Q4 		$8.66M Sell
82,226
-23,781
-22% -$2.23M 1.55% 17
2025
Q3 		$8.9M Sell
106,007
-3,710
-3% -$306K 1.51% 17
2025
Q2 		$8.69M Buy
109,717
+11,291
+11% +$898K 1.55% 15
2025
Q1 		$8.84M Sell
98,426
-7,575
-7% -$707K 1.87% 12
2024
Q4 		$10.5M Sell
106,001
-5,056
-5% -$521K 2.2% 10
2024
Q3 		$12.5M Buy
111,057
+14,780
+15% +$1.76M 2.22% 10
2024
Q2 		$11.9M Sell
96,277
-8,409
-8% -$1.08M 2.29% 9
2024
Q1 		$13.8M Sell
104,686
-10,070
-9% -$1.24M 2.4% 5
2023
Q4 		$12.5M Sell
114,756
-19,291
-14% -$2M 2.37% 5
2023
Q3 		$13.8M Sell
134,047
-1,820
-1% -$196K 2.24% 7
2023
Q2 		$15.7M Buy
135,867
+10,810
+9% +$1.23M 2.14% 7
2023
Q1 		$13.3M Buy
125,057
+2,875
+2% +$310K 1.91% 9
2022
Q4 		$13.6M Sell
122,182
-5,055
-4% -$517K 2.12% 7
2022
Q3 		$11M Sell
127,237
-12,095
-9% -$1.08M 1.86% 9
2022
Q2 		$12.7M Sell
139,332
-1,740
-1% -$154K 1.92% 9
2022
Q1 		$11.6M Buy
141,072
+7,820
+6% +$617K 1.57% 17
2021
Q4 		$10.2M Buy
133,252
+400
+0.3% +$31.9K 1.32% 26
2021
Q3 		$9.98M Buy
132,852
+3,400
+3% +$259K 1.38% 20
2021
Q2 		$10.1M Sell
129,452
-20,393
-14% -$1.52M 1.32% 21
2021
Q1 		$11M Buy
149,845
+29,134
+24% +$2.15M 1.41% 21
2020
Q4 		$9.42M Buy
120,711
+23,895
+25% +$1.83M 1.31% 20
2020
Q3 		$7.66M Buy
+96,816
New +$7.58M 1.31% 24

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Te Ahumairangi Investment Management's MRK Position: Q1 2026 in Review

Te Ahumairangi Investment Management reduced its Merck (MRK) stake by 23% in Q1 2026, selling an estimated $2.15M and leaving 63,569 shares worth $7.65M. The position accounts for 1.28% of the portfolio, ranked #25.

Te Ahumairangi Investment Management first reported a position in MRK in Q3 2020 and has held it in 23 quarters since. The position peaked at $15.7M in Q2 2023. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Te Ahumairangi Investment Management held 63,569 shares of Merck worth $7.65M as of Q1 2026.
  • Te Ahumairangi Investment Management sold 18,657 Merck shares in Q1 2026, an estimated $2.15M.
  • Merck made up 1.28% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #25 holding.
  • Te Ahumairangi Investment Management first reported a position in Merck in Q3 2020 and has held it in 23 quarters since.
  • Te Ahumairangi Investment Management's Merck position peaked at $15.7M in Q2 2023.
  • 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.